BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16356871)

  • 1. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology.
    Sotiropoulos GC; Malagó M; Molmenti E; Paul A; Nadalin S; Brokalaki EI; Verhagen R; Dirsch O; Gerken G; Lang H; Broelsch CE
    Hepatogastroenterology; 2005; 52(62):329-32. PubMed ID: 15816428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of superselective chemoembolization and radiofrequency ablation of hepatocellular carcinoma assessed in 21 explanted livers.
    Lang EK; Brammer M; Charafeddine R; Regenstein F; Haque S; Florman S; Cline K; Slakey D
    J La State Med Soc; 2008; 160(5):258-62. PubMed ID: 19048980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
    Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
    Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J; He X; Lin X; Zhang C; Li J
    Chin Med J (Engl); 2000 May; 113(5):446-8. PubMed ID: 11776102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A
    J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.